NCT01750567View on ClinicalTrials.gov

A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Relapsed Chronic Lymphocytic Leukemia
Interventions
DRUG

Metformin

Metformin is an antidiabetic drug which is an inexpensive and generally well tolerated medication.

Trial Locations (1)

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT01750567 - A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL | Biotech Hunter | Biotech Hunter